Table 3 Descriptive statistics and clinicopathologic characteristics for patients included in in silico analysis of KIFC1 expression and overall survival

Age (Range)

20–29

1

0.5

30–39

4

1.9

40–49

23

11.1

50–59

84

40.4

60–69

54

26

70–79

40

19.2

80–89

1

0.5

Unknown

1

0.5

Cancer site

Primary

154

74

Metastasis

50

24

Unknown

4

1.9

FIGO Stage

I

9

4.3

II

9

4.3

III

126

60.6

IV

10

4.8

Unknown

54

26

Grade

1

6

2.9

2

80

38.5

3

120

57.7

Unknown

2

1

Survival Status

Alive

109

52.4

Dead

98

47.1

Unknown

1

0.5

Recurrence

Recurrence

154

74

No Recurrence

53

25.5

Unknown

1

0.5